Cartesian Therapeutics Inc (RNAC) Directors and Executive Officers

Officers & Directors

Carrie S. Cox
Director

Michael Singer, M.D., Ph.D.
Director

Patrick Zenner
Director

Carsten Brunn, Ph.D.
President and Chief Executive Officer, and Director

Timothy Springer, Ph.D.
Director

Blaine Davis
Chief Financial Officer

Timothy C. Barabe
Director

Nishan de Silva, M.D.
Director

Murat Kalayoglu, M.D., Ph.D.
Director ,

Cartesian Therapeutics Inc currently has 75 employees.

News about Cartesian Therapeutics Inc Key Personnel

Cartesian Therapeutics Boosts Talent Acquisition with New Inducement Grant Amidst Steady Revenue Performance

In a strategic move to attract top-tier talent, Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a pioneering biotechnology company focused on mRNA cell therapies for autoimmune diseases, has recently announced the granting of an employment inducement award to a new employee. This initiative underscores the organization s commitment to enhancing human capital, a critical component in the highly competitive biotech sector.On March 3, 2025, Cartesian Therapeutics awarded an option to purchase 2,650 shares of the company s common stock, with an exercise price set at $17.50—reflecting the closing trading price of the company s stock on the Nasdaq Global Market at the time of the grant. This incentive was made unde...